Global Hepatitis A immunoglobulin Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
The global market for Hepatitis A immunoglobulin is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Hepatitis A immunoglobulin market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Hepatitis A immunoglobulin market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Hepatitis A immunoglobulin market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Hepatitis A immunoglobulin market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Hepatitis A immunoglobulin players cover CSL Behring, AIM Vaccine, Sinovac Biotech, Pukang Biotechnology and Zhifei Biological Products, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Hepatitis A immunoglobulin market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Hepatitis A immunoglobulin market, with both quantitative and qualitative data, to help readers understand how the Hepatitis A immunoglobulin market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Doses.
Market Segmentation:
The study segments the Hepatitis A immunoglobulin market and forecasts the market size by Type (Inactivated and Attenuated,), by Application (Hospital, Pharmacy and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Chapter 1: Scope of Hepatitis A immunoglobulin, Research Methodology, etc.
Chapter 2: Executive Summary, global Hepatitis A immunoglobulin market size (sales and revenue) and CAGR, Hepatitis A immunoglobulin market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Hepatitis A immunoglobulin sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Hepatitis A immunoglobulin sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Hepatitis A immunoglobulin market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including CSL Behring, AIM Vaccine, Sinovac Biotech, Pukang Biotechnology, Zhifei Biological Products, Changchun Lnstitute Of Biological Products, Native Antigen, GSK and Merck, etc.
Chapter 14: Research Findings and Conclusion
The global market for Hepatitis A immunoglobulin is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Hepatitis A immunoglobulin market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Hepatitis A immunoglobulin market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Hepatitis A immunoglobulin market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Hepatitis A immunoglobulin market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Hepatitis A immunoglobulin players cover CSL Behring, AIM Vaccine, Sinovac Biotech, Pukang Biotechnology and Zhifei Biological Products, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Hepatitis A immunoglobulin market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Hepatitis A immunoglobulin market, with both quantitative and qualitative data, to help readers understand how the Hepatitis A immunoglobulin market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Doses.
Market Segmentation:
The study segments the Hepatitis A immunoglobulin market and forecasts the market size by Type (Inactivated and Attenuated,), by Application (Hospital, Pharmacy and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
- Inactivated
- Attenuated
- Hospital
- Pharmacy
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- CSL Behring
- AIM Vaccine
- Sinovac Biotech
- Pukang Biotechnology
- Zhifei Biological Products
- Changchun Lnstitute Of Biological Products
- Native Antigen
- GSK
- Merck
- Sanofi
- Dr. Reddy's Laboratories
Chapter 1: Scope of Hepatitis A immunoglobulin, Research Methodology, etc.
Chapter 2: Executive Summary, global Hepatitis A immunoglobulin market size (sales and revenue) and CAGR, Hepatitis A immunoglobulin market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Hepatitis A immunoglobulin sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Hepatitis A immunoglobulin sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Hepatitis A immunoglobulin market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including CSL Behring, AIM Vaccine, Sinovac Biotech, Pukang Biotechnology, Zhifei Biological Products, Changchun Lnstitute Of Biological Products, Native Antigen, GSK and Merck, etc.
Chapter 14: Research Findings and Conclusion
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hepatitis A immunoglobulin Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Hepatitis A immunoglobulin by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Hepatitis A immunoglobulin by Country/Region, 2017, 2022 & 2028
2.2 Hepatitis A immunoglobulin Segment by Type
2.2.1 Inactivated
2.2.2 Attenuated
2.3 Hepatitis A immunoglobulin Sales by Type
2.3.1 Global Hepatitis A immunoglobulin Sales Market Share by Type (2017-2022)
2.3.2 Global Hepatitis A immunoglobulin Revenue and Market Share by Type (2017-2022)
2.3.3 Global Hepatitis A immunoglobulin Sale Price by Type (2017-2022)
2.4 Hepatitis A immunoglobulin Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.4.3 Other
2.5 Hepatitis A immunoglobulin Sales by Application
2.5.1 Global Hepatitis A immunoglobulin Sale Market Share by Application (2017-2022)
2.5.2 Global Hepatitis A immunoglobulin Revenue and Market Share by Application (2017-2022)
2.5.3 Global Hepatitis A immunoglobulin Sale Price by Application (2017-2022)
3 GLOBAL HEPATITIS A IMMUNOGLOBULIN BY COMPANY
3.1 Global Hepatitis A immunoglobulin Breakdown Data by Company
3.1.1 Global Hepatitis A immunoglobulin Annual Sales by Company (2020-2022)
3.1.2 Global Hepatitis A immunoglobulin Sales Market Share by Company (2020-2022)
3.2 Global Hepatitis A immunoglobulin Annual Revenue by Company (2020-2022)
3.2.1 Global Hepatitis A immunoglobulin Revenue by Company (2020-2022)
3.2.2 Global Hepatitis A immunoglobulin Revenue Market Share by Company (2020-2022)
3.3 Global Hepatitis A immunoglobulin Sale Price by Company
3.4 Key Manufacturers Hepatitis A immunoglobulin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hepatitis A immunoglobulin Product Location Distribution
3.4.2 Players Hepatitis A immunoglobulin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR HEPATITIS A IMMUNOGLOBULIN BY GEOGRAPHIC REGION
4.1 World Historic Hepatitis A immunoglobulin Market Size by Geographic Region (2017-2022)
4.1.1 Global Hepatitis A immunoglobulin Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Hepatitis A immunoglobulin Annual Revenue by Geographic Region
4.2 World Historic Hepatitis A immunoglobulin Market Size by Country/Region (2017-2022)
4.2.1 Global Hepatitis A immunoglobulin Annual Sales by Country/Region (2017-2022)
4.2.2 Global Hepatitis A immunoglobulin Annual Revenue by Country/Region
4.3 Americas Hepatitis A immunoglobulin Sales Growth
4.4 APAC Hepatitis A immunoglobulin Sales Growth
4.5 Europe Hepatitis A immunoglobulin Sales Growth
4.6 Middle East & Africa Hepatitis A immunoglobulin Sales Growth
5 AMERICAS
5.1 Americas Hepatitis A immunoglobulin Sales by Country
5.1.1 Americas Hepatitis A immunoglobulin Sales by Country (2017-2022)
5.1.2 Americas Hepatitis A immunoglobulin Revenue by Country (2017-2022)
5.2 Americas Hepatitis A immunoglobulin Sales by Type
5.3 Americas Hepatitis A immunoglobulin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hepatitis A immunoglobulin Sales by Region
6.1.1 APAC Hepatitis A immunoglobulin Sales by Region (2017-2022)
6.1.2 APAC Hepatitis A immunoglobulin Revenue by Region (2017-2022)
6.2 APAC Hepatitis A immunoglobulin Sales by Type
6.3 APAC Hepatitis A immunoglobulin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Hepatitis A immunoglobulin by Country
7.1.1 Europe Hepatitis A immunoglobulin Sales by Country (2017-2022)
7.1.2 Europe Hepatitis A immunoglobulin Revenue by Country (2017-2022)
7.2 Europe Hepatitis A immunoglobulin Sales by Type
7.3 Europe Hepatitis A immunoglobulin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hepatitis A immunoglobulin by Country
8.1.1 Middle East & Africa Hepatitis A immunoglobulin Sales by Country (2017-2022)
8.1.2 Middle East & Africa Hepatitis A immunoglobulin Revenue by Country (2017-2022)
8.2 Middle East & Africa Hepatitis A immunoglobulin Sales by Type
8.3 Middle East & Africa Hepatitis A immunoglobulin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hepatitis A immunoglobulin
10.3 Manufacturing Process Analysis of Hepatitis A immunoglobulin
10.4 Industry Chain Structure of Hepatitis A immunoglobulin
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hepatitis A immunoglobulin Distributors
11.3 Hepatitis A immunoglobulin Customer
12 WORLD FORECAST REVIEW FOR HEPATITIS A IMMUNOGLOBULIN BY GEOGRAPHIC REGION
12.1 Global Hepatitis A immunoglobulin Market Size Forecast by Region
12.1.1 Global Hepatitis A immunoglobulin Forecast by Region (2023-2028)
12.1.2 Global Hepatitis A immunoglobulin Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Hepatitis A immunoglobulin Forecast by Type
12.7 Global Hepatitis A immunoglobulin Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 CSL Behring
13.1.1 CSL Behring Company Information
13.1.2 CSL Behring Hepatitis A immunoglobulin Product Offered
13.1.3 CSL Behring Hepatitis A immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 CSL Behring Main Business Overview
13.1.5 CSL Behring Latest Developments
13.2 AIM Vaccine
13.2.1 AIM Vaccine Company Information
13.2.2 AIM Vaccine Hepatitis A immunoglobulin Product Offered
13.2.3 AIM Vaccine Hepatitis A immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 AIM Vaccine Main Business Overview
13.2.5 AIM Vaccine Latest Developments
13.3 Sinovac Biotech
13.3.1 Sinovac Biotech Company Information
13.3.2 Sinovac Biotech Hepatitis A immunoglobulin Product Offered
13.3.3 Sinovac Biotech Hepatitis A immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Sinovac Biotech Main Business Overview
13.3.5 Sinovac Biotech Latest Developments
13.4 Pukang Biotechnology
13.4.1 Pukang Biotechnology Company Information
13.4.2 Pukang Biotechnology Hepatitis A immunoglobulin Product Offered
13.4.3 Pukang Biotechnology Hepatitis A immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Pukang Biotechnology Main Business Overview
13.4.5 Pukang Biotechnology Latest Developments
13.5 Zhifei Biological Products
13.5.1 Zhifei Biological Products Company Information
13.5.2 Zhifei Biological Products Hepatitis A immunoglobulin Product Offered
13.5.3 Zhifei Biological Products Hepatitis A immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Zhifei Biological Products Main Business Overview
13.5.5 Zhifei Biological Products Latest Developments
13.6 Changchun Lnstitute Of Biological Products
13.6.1 Changchun Lnstitute Of Biological Products Company Information
13.6.2 Changchun Lnstitute Of Biological Products Hepatitis A immunoglobulin Product Offered
13.6.3 Changchun Lnstitute Of Biological Products Hepatitis A immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Changchun Lnstitute Of Biological Products Main Business Overview
13.6.5 Changchun Lnstitute Of Biological Products Latest Developments
13.7 Native Antigen
13.7.1 Native Antigen Company Information
13.7.2 Native Antigen Hepatitis A immunoglobulin Product Offered
13.7.3 Native Antigen Hepatitis A immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Native Antigen Main Business Overview
13.7.5 Native Antigen Latest Developments
13.8 GSK
13.8.1 GSK Company Information
13.8.2 GSK Hepatitis A immunoglobulin Product Offered
13.8.3 GSK Hepatitis A immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 GSK Main Business Overview
13.8.5 GSK Latest Developments
13.9 Merck
13.9.1 Merck Company Information
13.9.2 Merck Hepatitis A immunoglobulin Product Offered
13.9.3 Merck Hepatitis A immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Merck Main Business Overview
13.9.5 Merck Latest Developments
13.10 Sanofi
13.10.1 Sanofi Company Information
13.10.2 Sanofi Hepatitis A immunoglobulin Product Offered
13.10.3 Sanofi Hepatitis A immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Sanofi Main Business Overview
13.10.5 Sanofi Latest Developments
13.11 Dr. Reddy's Laboratories
13.11.1 Dr. Reddy's Laboratories Company Information
13.11.2 Dr. Reddy's Laboratories Hepatitis A immunoglobulin Product Offered
13.11.3 Dr. Reddy's Laboratories Hepatitis A immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Dr. Reddy's Laboratories Main Business Overview
13.11.5 Dr. Reddy's Laboratories Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hepatitis A immunoglobulin Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Hepatitis A immunoglobulin by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Hepatitis A immunoglobulin by Country/Region, 2017, 2022 & 2028
2.2 Hepatitis A immunoglobulin Segment by Type
2.2.1 Inactivated
2.2.2 Attenuated
2.3 Hepatitis A immunoglobulin Sales by Type
2.3.1 Global Hepatitis A immunoglobulin Sales Market Share by Type (2017-2022)
2.3.2 Global Hepatitis A immunoglobulin Revenue and Market Share by Type (2017-2022)
2.3.3 Global Hepatitis A immunoglobulin Sale Price by Type (2017-2022)
2.4 Hepatitis A immunoglobulin Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.4.3 Other
2.5 Hepatitis A immunoglobulin Sales by Application
2.5.1 Global Hepatitis A immunoglobulin Sale Market Share by Application (2017-2022)
2.5.2 Global Hepatitis A immunoglobulin Revenue and Market Share by Application (2017-2022)
2.5.3 Global Hepatitis A immunoglobulin Sale Price by Application (2017-2022)
3 GLOBAL HEPATITIS A IMMUNOGLOBULIN BY COMPANY
3.1 Global Hepatitis A immunoglobulin Breakdown Data by Company
3.1.1 Global Hepatitis A immunoglobulin Annual Sales by Company (2020-2022)
3.1.2 Global Hepatitis A immunoglobulin Sales Market Share by Company (2020-2022)
3.2 Global Hepatitis A immunoglobulin Annual Revenue by Company (2020-2022)
3.2.1 Global Hepatitis A immunoglobulin Revenue by Company (2020-2022)
3.2.2 Global Hepatitis A immunoglobulin Revenue Market Share by Company (2020-2022)
3.3 Global Hepatitis A immunoglobulin Sale Price by Company
3.4 Key Manufacturers Hepatitis A immunoglobulin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hepatitis A immunoglobulin Product Location Distribution
3.4.2 Players Hepatitis A immunoglobulin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR HEPATITIS A IMMUNOGLOBULIN BY GEOGRAPHIC REGION
4.1 World Historic Hepatitis A immunoglobulin Market Size by Geographic Region (2017-2022)
4.1.1 Global Hepatitis A immunoglobulin Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Hepatitis A immunoglobulin Annual Revenue by Geographic Region
4.2 World Historic Hepatitis A immunoglobulin Market Size by Country/Region (2017-2022)
4.2.1 Global Hepatitis A immunoglobulin Annual Sales by Country/Region (2017-2022)
4.2.2 Global Hepatitis A immunoglobulin Annual Revenue by Country/Region
4.3 Americas Hepatitis A immunoglobulin Sales Growth
4.4 APAC Hepatitis A immunoglobulin Sales Growth
4.5 Europe Hepatitis A immunoglobulin Sales Growth
4.6 Middle East & Africa Hepatitis A immunoglobulin Sales Growth
5 AMERICAS
5.1 Americas Hepatitis A immunoglobulin Sales by Country
5.1.1 Americas Hepatitis A immunoglobulin Sales by Country (2017-2022)
5.1.2 Americas Hepatitis A immunoglobulin Revenue by Country (2017-2022)
5.2 Americas Hepatitis A immunoglobulin Sales by Type
5.3 Americas Hepatitis A immunoglobulin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hepatitis A immunoglobulin Sales by Region
6.1.1 APAC Hepatitis A immunoglobulin Sales by Region (2017-2022)
6.1.2 APAC Hepatitis A immunoglobulin Revenue by Region (2017-2022)
6.2 APAC Hepatitis A immunoglobulin Sales by Type
6.3 APAC Hepatitis A immunoglobulin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Hepatitis A immunoglobulin by Country
7.1.1 Europe Hepatitis A immunoglobulin Sales by Country (2017-2022)
7.1.2 Europe Hepatitis A immunoglobulin Revenue by Country (2017-2022)
7.2 Europe Hepatitis A immunoglobulin Sales by Type
7.3 Europe Hepatitis A immunoglobulin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hepatitis A immunoglobulin by Country
8.1.1 Middle East & Africa Hepatitis A immunoglobulin Sales by Country (2017-2022)
8.1.2 Middle East & Africa Hepatitis A immunoglobulin Revenue by Country (2017-2022)
8.2 Middle East & Africa Hepatitis A immunoglobulin Sales by Type
8.3 Middle East & Africa Hepatitis A immunoglobulin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hepatitis A immunoglobulin
10.3 Manufacturing Process Analysis of Hepatitis A immunoglobulin
10.4 Industry Chain Structure of Hepatitis A immunoglobulin
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hepatitis A immunoglobulin Distributors
11.3 Hepatitis A immunoglobulin Customer
12 WORLD FORECAST REVIEW FOR HEPATITIS A IMMUNOGLOBULIN BY GEOGRAPHIC REGION
12.1 Global Hepatitis A immunoglobulin Market Size Forecast by Region
12.1.1 Global Hepatitis A immunoglobulin Forecast by Region (2023-2028)
12.1.2 Global Hepatitis A immunoglobulin Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Hepatitis A immunoglobulin Forecast by Type
12.7 Global Hepatitis A immunoglobulin Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 CSL Behring
13.1.1 CSL Behring Company Information
13.1.2 CSL Behring Hepatitis A immunoglobulin Product Offered
13.1.3 CSL Behring Hepatitis A immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 CSL Behring Main Business Overview
13.1.5 CSL Behring Latest Developments
13.2 AIM Vaccine
13.2.1 AIM Vaccine Company Information
13.2.2 AIM Vaccine Hepatitis A immunoglobulin Product Offered
13.2.3 AIM Vaccine Hepatitis A immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 AIM Vaccine Main Business Overview
13.2.5 AIM Vaccine Latest Developments
13.3 Sinovac Biotech
13.3.1 Sinovac Biotech Company Information
13.3.2 Sinovac Biotech Hepatitis A immunoglobulin Product Offered
13.3.3 Sinovac Biotech Hepatitis A immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Sinovac Biotech Main Business Overview
13.3.5 Sinovac Biotech Latest Developments
13.4 Pukang Biotechnology
13.4.1 Pukang Biotechnology Company Information
13.4.2 Pukang Biotechnology Hepatitis A immunoglobulin Product Offered
13.4.3 Pukang Biotechnology Hepatitis A immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Pukang Biotechnology Main Business Overview
13.4.5 Pukang Biotechnology Latest Developments
13.5 Zhifei Biological Products
13.5.1 Zhifei Biological Products Company Information
13.5.2 Zhifei Biological Products Hepatitis A immunoglobulin Product Offered
13.5.3 Zhifei Biological Products Hepatitis A immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Zhifei Biological Products Main Business Overview
13.5.5 Zhifei Biological Products Latest Developments
13.6 Changchun Lnstitute Of Biological Products
13.6.1 Changchun Lnstitute Of Biological Products Company Information
13.6.2 Changchun Lnstitute Of Biological Products Hepatitis A immunoglobulin Product Offered
13.6.3 Changchun Lnstitute Of Biological Products Hepatitis A immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Changchun Lnstitute Of Biological Products Main Business Overview
13.6.5 Changchun Lnstitute Of Biological Products Latest Developments
13.7 Native Antigen
13.7.1 Native Antigen Company Information
13.7.2 Native Antigen Hepatitis A immunoglobulin Product Offered
13.7.3 Native Antigen Hepatitis A immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Native Antigen Main Business Overview
13.7.5 Native Antigen Latest Developments
13.8 GSK
13.8.1 GSK Company Information
13.8.2 GSK Hepatitis A immunoglobulin Product Offered
13.8.3 GSK Hepatitis A immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 GSK Main Business Overview
13.8.5 GSK Latest Developments
13.9 Merck
13.9.1 Merck Company Information
13.9.2 Merck Hepatitis A immunoglobulin Product Offered
13.9.3 Merck Hepatitis A immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Merck Main Business Overview
13.9.5 Merck Latest Developments
13.10 Sanofi
13.10.1 Sanofi Company Information
13.10.2 Sanofi Hepatitis A immunoglobulin Product Offered
13.10.3 Sanofi Hepatitis A immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Sanofi Main Business Overview
13.10.5 Sanofi Latest Developments
13.11 Dr. Reddy's Laboratories
13.11.1 Dr. Reddy's Laboratories Company Information
13.11.2 Dr. Reddy's Laboratories Hepatitis A immunoglobulin Product Offered
13.11.3 Dr. Reddy's Laboratories Hepatitis A immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Dr. Reddy's Laboratories Main Business Overview
13.11.5 Dr. Reddy's Laboratories Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Hepatitis A immunoglobulin Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Hepatitis A immunoglobulin Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Inactivated
Table 4. Major Players of Attenuated
Table 5. Global Hepatitis A immunoglobulin Sales by Type (2017-2022) & (Doses)
Table 6. Global Hepatitis A immunoglobulin Sales Market Share by Type (2017-2022)
Table 7. Global Hepatitis A immunoglobulin Revenue by Type (2017-2022) & ($ million)
Table 8. Global Hepatitis A immunoglobulin Revenue Market Share by Type (2017-2022)
Table 9. Global Hepatitis A immunoglobulin Sale Price by Type (2017-2022) & (US$/Dose)
Table 10. Global Hepatitis A immunoglobulin Sales by Application (2017-2022) & (Doses)
Table 11. Global Hepatitis A immunoglobulin Sales Market Share by Application (2017-2022)
Table 12. Global Hepatitis A immunoglobulin Revenue by Application (2017-2022)
Table 13. Global Hepatitis A immunoglobulin Revenue Market Share by Application (2017-2022)
Table 14. Global Hepatitis A immunoglobulin Sale Price by Application (2017-2022) & (US$/Dose)
Table 15. Global Hepatitis A immunoglobulin Sales by Company (2020-2022) & (Doses)
Table 16. Global Hepatitis A immunoglobulin Sales Market Share by Company (2020-2022)
Table 17. Global Hepatitis A immunoglobulin Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Hepatitis A immunoglobulin Revenue Market Share by Company (2020-2022)
Table 19. Global Hepatitis A immunoglobulin Sale Price by Company (2020-2022) & (US$/Dose)
Table 20. Key Manufacturers Hepatitis A immunoglobulin Producing Area Distribution and Sales Area
Table 21. Players Hepatitis A immunoglobulin Products Offered
Table 22. Hepatitis A immunoglobulin Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Hepatitis A immunoglobulin Sales by Geographic Region (2017-2022) & (Doses)
Table 26. Global Hepatitis A immunoglobulin Sales Market Share Geographic Region (2017-2022)
Table 27. Global Hepatitis A immunoglobulin Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Hepatitis A immunoglobulin Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Hepatitis A immunoglobulin Sales by Country/Region (2017-2022) & (Doses)
Table 30. Global Hepatitis A immunoglobulin Sales Market Share by Country/Region (2017-2022)
Table 31. Global Hepatitis A immunoglobulin Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Hepatitis A immunoglobulin Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Hepatitis A immunoglobulin Sales by Country (2017-2022) & (Doses)
Table 34. Americas Hepatitis A immunoglobulin Sales Market Share by Country (2017-2022)
Table 35. Americas Hepatitis A immunoglobulin Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Hepatitis A immunoglobulin Revenue Market Share by Country (2017-2022)
Table 37. Americas Hepatitis A immunoglobulin Sales by Type (2017-2022) & (Doses)
Table 38. Americas Hepatitis A immunoglobulin Sales Market Share by Type (2017-2022)
Table 39. Americas Hepatitis A immunoglobulin Sales by Application (2017-2022) & (Doses)
Table 40. Americas Hepatitis A immunoglobulin Sales Market Share by Application (2017-2022)
Table 41. APAC Hepatitis A immunoglobulin Sales by Region (2017-2022) & (Doses)
Table 42. APAC Hepatitis A immunoglobulin Sales Market Share by Region (2017-2022)
Table 43. APAC Hepatitis A immunoglobulin Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Hepatitis A immunoglobulin Revenue Market Share by Region (2017-2022)
Table 45. APAC Hepatitis A immunoglobulin Sales by Type (2017-2022) & (Doses)
Table 46. APAC Hepatitis A immunoglobulin Sales Market Share by Type (2017-2022)
Table 47. APAC Hepatitis A immunoglobulin Sales by Application (2017-2022) & (Doses)
Table 48. APAC Hepatitis A immunoglobulin Sales Market Share by Application (2017-2022)
Table 49. Europe Hepatitis A immunoglobulin Sales by Country (2017-2022) & (Doses)
Table 50. Europe Hepatitis A immunoglobulin Sales Market Share by Country (2017-2022)
Table 51. Europe Hepatitis A immunoglobulin Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Hepatitis A immunoglobulin Revenue Market Share by Country (2017-2022)
Table 53. Europe Hepatitis A immunoglobulin Sales by Type (2017-2022) & (Doses)
Table 54. Europe Hepatitis A immunoglobulin Sales Market Share by Type (2017-2022)
Table 55. Europe Hepatitis A immunoglobulin Sales by Application (2017-2022) & (Doses)
Table 56. Europe Hepatitis A immunoglobulin Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Hepatitis A immunoglobulin Sales by Country (2017-2022) & (Doses)
Table 58. Middle East & Africa Hepatitis A immunoglobulin Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Hepatitis A immunoglobulin Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Hepatitis A immunoglobulin Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Hepatitis A immunoglobulin Sales by Type (2017-2022) & (Doses)
Table 62. Middle East & Africa Hepatitis A immunoglobulin Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Hepatitis A immunoglobulin Sales by Application (2017-2022) & (Doses)
Table 64. Middle East & Africa Hepatitis A immunoglobulin Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Hepatitis A immunoglobulin
Table 66. Key Market Challenges & Risks of Hepatitis A immunoglobulin
Table 67. Key Industry Trends of Hepatitis A immunoglobulin
Table 68. Hepatitis A immunoglobulin Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Hepatitis A immunoglobulin Distributors List
Table 71. Hepatitis A immunoglobulin Customer List
Table 72. Global Hepatitis A immunoglobulin Sales Forecast by Region (2023-2028) & (Doses)
Table 73. Global Hepatitis A immunoglobulin Sales Market Forecast by Region
Table 74. Global Hepatitis A immunoglobulin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Hepatitis A immunoglobulin Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Hepatitis A immunoglobulin Sales Forecast by Country (2023-2028) & (Doses)
Table 77. Americas Hepatitis A immunoglobulin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Hepatitis A immunoglobulin Sales Forecast by Region (2023-2028) & (Doses)
Table 79. APAC Hepatitis A immunoglobulin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Hepatitis A immunoglobulin Sales Forecast by Country (2023-2028) & (Doses)
Table 81. Europe Hepatitis A immunoglobulin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Hepatitis A immunoglobulin Sales Forecast by Country (2023-2028) & (Doses)
Table 83. Middle East & Africa Hepatitis A immunoglobulin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Hepatitis A immunoglobulin Sales Forecast by Type (2023-2028) & (Doses)
Table 85. Global Hepatitis A immunoglobulin Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Hepatitis A immunoglobulin Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Hepatitis A immunoglobulin Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Hepatitis A immunoglobulin Sales Forecast by Application (2023-2028) & (Doses)
Table 89. Global Hepatitis A immunoglobulin Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Hepatitis A immunoglobulin Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Hepatitis A immunoglobulin Revenue Market Share Forecast by Application (2023-2028)
Table 92. CSL Behring Basic Information, Hepatitis A immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 93. CSL Behring Hepatitis A immunoglobulin Product Offered
Table 94. CSL Behring Hepatitis A immunoglobulin Sales (Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 95. CSL Behring Main Business
Table 96. CSL Behring Latest Developments
Table 97. AIM Vaccine Basic Information, Hepatitis A immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 98. AIM Vaccine Hepatitis A immunoglobulin Product Offered
Table 99. AIM Vaccine Hepatitis A immunoglobulin Sales (Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 100. AIM Vaccine Main Business
Table 101. AIM Vaccine Latest Developments
Table 102. Sinovac Biotech Basic Information, Hepatitis A immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 103. Sinovac Biotech Hepatitis A immunoglobulin Product Offered
Table 104. Sinovac Biotech Hepatitis A immunoglobulin Sales (Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 105. Sinovac Biotech Main Business
Table 106. Sinovac Biotech Latest Developments
Table 107. Pukang Biotechnology Basic Information, Hepatitis A immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 108. Pukang Biotechnology Hepatitis A immunoglobulin Product Offered
Table 109. Pukang Biotechnology Hepatitis A immunoglobulin Sales (Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 110. Pukang Biotechnology Main Business
Table 111. Pukang Biotechnology Latest Developments
Table 112. Zhifei Biological Products Basic Information, Hepatitis A immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 113. Zhifei Biological Products Hepatitis A immunoglobulin Product Offered
Table 114. Zhifei Biological Products Hepatitis A immunoglobulin Sales (Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 115. Zhifei Biological Products Main Business
Table 116. Zhifei Biological Products Latest Developments
Table 117. Changchun Lnstitute Of Biological Products Basic Information, Hepatitis A immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 118. Changchun Lnstitute Of Biological Products Hepatitis A immunoglobulin Product Offered
Table 119. Changchun Lnstitute Of Biological Products Hepatitis A immunoglobulin Sales (Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 120. Changchun Lnstitute Of Biological Products Main Business
Table 121. Changchun Lnstitute Of Biological Products Latest Developments
Table 122. Native Antigen Basic Information, Hepatitis A immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 123. Native Antigen Hepatitis A immunoglobulin Product Offered
Table 124. Native Antigen Hepatitis A immunoglobulin Sales (Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 125. Native Antigen Main Business
Table 126. Native Antigen Latest Developments
Table 127. GSK Basic Information, Hepatitis A immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 128. GSK Hepatitis A immunoglobulin Product Offered
Table 129. GSK Hepatitis A immunoglobulin Sales (Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 130. GSK Main Business
Table 131. GSK Latest Developments
Table 132. Merck Basic Information, Hepatitis A immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 133. Merck Hepatitis A immunoglobulin Product Offered
Table 134. Merck Hepatitis A immunoglobulin Sales (Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 135. Merck Main Business
Table 136. Merck Latest Developments
Table 137. Sanofi Basic Information, Hepatitis A immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 138. Sanofi Hepatitis A immunoglobulin Product Offered
Table 139. Sanofi Hepatitis A immunoglobulin Sales (Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 140. Sanofi Main Business
Table 141. Sanofi Latest Developments
Table 142. Dr. Reddy's Laboratories Basic Information, Hepatitis A immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 143. Dr. Reddy's Laboratories Hepatitis A immunoglobulin Product Offered
Table 144. Dr. Reddy's Laboratories Hepatitis A immunoglobulin Sales (Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 145. Dr. Reddy's Laboratories Main Business
Table 146. Dr. Reddy's Laboratories Latest Developments
Table 1. Hepatitis A immunoglobulin Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Hepatitis A immunoglobulin Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Inactivated
Table 4. Major Players of Attenuated
Table 5. Global Hepatitis A immunoglobulin Sales by Type (2017-2022) & (Doses)
Table 6. Global Hepatitis A immunoglobulin Sales Market Share by Type (2017-2022)
Table 7. Global Hepatitis A immunoglobulin Revenue by Type (2017-2022) & ($ million)
Table 8. Global Hepatitis A immunoglobulin Revenue Market Share by Type (2017-2022)
Table 9. Global Hepatitis A immunoglobulin Sale Price by Type (2017-2022) & (US$/Dose)
Table 10. Global Hepatitis A immunoglobulin Sales by Application (2017-2022) & (Doses)
Table 11. Global Hepatitis A immunoglobulin Sales Market Share by Application (2017-2022)
Table 12. Global Hepatitis A immunoglobulin Revenue by Application (2017-2022)
Table 13. Global Hepatitis A immunoglobulin Revenue Market Share by Application (2017-2022)
Table 14. Global Hepatitis A immunoglobulin Sale Price by Application (2017-2022) & (US$/Dose)
Table 15. Global Hepatitis A immunoglobulin Sales by Company (2020-2022) & (Doses)
Table 16. Global Hepatitis A immunoglobulin Sales Market Share by Company (2020-2022)
Table 17. Global Hepatitis A immunoglobulin Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Hepatitis A immunoglobulin Revenue Market Share by Company (2020-2022)
Table 19. Global Hepatitis A immunoglobulin Sale Price by Company (2020-2022) & (US$/Dose)
Table 20. Key Manufacturers Hepatitis A immunoglobulin Producing Area Distribution and Sales Area
Table 21. Players Hepatitis A immunoglobulin Products Offered
Table 22. Hepatitis A immunoglobulin Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Hepatitis A immunoglobulin Sales by Geographic Region (2017-2022) & (Doses)
Table 26. Global Hepatitis A immunoglobulin Sales Market Share Geographic Region (2017-2022)
Table 27. Global Hepatitis A immunoglobulin Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Hepatitis A immunoglobulin Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Hepatitis A immunoglobulin Sales by Country/Region (2017-2022) & (Doses)
Table 30. Global Hepatitis A immunoglobulin Sales Market Share by Country/Region (2017-2022)
Table 31. Global Hepatitis A immunoglobulin Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Hepatitis A immunoglobulin Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Hepatitis A immunoglobulin Sales by Country (2017-2022) & (Doses)
Table 34. Americas Hepatitis A immunoglobulin Sales Market Share by Country (2017-2022)
Table 35. Americas Hepatitis A immunoglobulin Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Hepatitis A immunoglobulin Revenue Market Share by Country (2017-2022)
Table 37. Americas Hepatitis A immunoglobulin Sales by Type (2017-2022) & (Doses)
Table 38. Americas Hepatitis A immunoglobulin Sales Market Share by Type (2017-2022)
Table 39. Americas Hepatitis A immunoglobulin Sales by Application (2017-2022) & (Doses)
Table 40. Americas Hepatitis A immunoglobulin Sales Market Share by Application (2017-2022)
Table 41. APAC Hepatitis A immunoglobulin Sales by Region (2017-2022) & (Doses)
Table 42. APAC Hepatitis A immunoglobulin Sales Market Share by Region (2017-2022)
Table 43. APAC Hepatitis A immunoglobulin Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Hepatitis A immunoglobulin Revenue Market Share by Region (2017-2022)
Table 45. APAC Hepatitis A immunoglobulin Sales by Type (2017-2022) & (Doses)
Table 46. APAC Hepatitis A immunoglobulin Sales Market Share by Type (2017-2022)
Table 47. APAC Hepatitis A immunoglobulin Sales by Application (2017-2022) & (Doses)
Table 48. APAC Hepatitis A immunoglobulin Sales Market Share by Application (2017-2022)
Table 49. Europe Hepatitis A immunoglobulin Sales by Country (2017-2022) & (Doses)
Table 50. Europe Hepatitis A immunoglobulin Sales Market Share by Country (2017-2022)
Table 51. Europe Hepatitis A immunoglobulin Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Hepatitis A immunoglobulin Revenue Market Share by Country (2017-2022)
Table 53. Europe Hepatitis A immunoglobulin Sales by Type (2017-2022) & (Doses)
Table 54. Europe Hepatitis A immunoglobulin Sales Market Share by Type (2017-2022)
Table 55. Europe Hepatitis A immunoglobulin Sales by Application (2017-2022) & (Doses)
Table 56. Europe Hepatitis A immunoglobulin Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Hepatitis A immunoglobulin Sales by Country (2017-2022) & (Doses)
Table 58. Middle East & Africa Hepatitis A immunoglobulin Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Hepatitis A immunoglobulin Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Hepatitis A immunoglobulin Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Hepatitis A immunoglobulin Sales by Type (2017-2022) & (Doses)
Table 62. Middle East & Africa Hepatitis A immunoglobulin Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Hepatitis A immunoglobulin Sales by Application (2017-2022) & (Doses)
Table 64. Middle East & Africa Hepatitis A immunoglobulin Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Hepatitis A immunoglobulin
Table 66. Key Market Challenges & Risks of Hepatitis A immunoglobulin
Table 67. Key Industry Trends of Hepatitis A immunoglobulin
Table 68. Hepatitis A immunoglobulin Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Hepatitis A immunoglobulin Distributors List
Table 71. Hepatitis A immunoglobulin Customer List
Table 72. Global Hepatitis A immunoglobulin Sales Forecast by Region (2023-2028) & (Doses)
Table 73. Global Hepatitis A immunoglobulin Sales Market Forecast by Region
Table 74. Global Hepatitis A immunoglobulin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Hepatitis A immunoglobulin Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Hepatitis A immunoglobulin Sales Forecast by Country (2023-2028) & (Doses)
Table 77. Americas Hepatitis A immunoglobulin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Hepatitis A immunoglobulin Sales Forecast by Region (2023-2028) & (Doses)
Table 79. APAC Hepatitis A immunoglobulin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Hepatitis A immunoglobulin Sales Forecast by Country (2023-2028) & (Doses)
Table 81. Europe Hepatitis A immunoglobulin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Hepatitis A immunoglobulin Sales Forecast by Country (2023-2028) & (Doses)
Table 83. Middle East & Africa Hepatitis A immunoglobulin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Hepatitis A immunoglobulin Sales Forecast by Type (2023-2028) & (Doses)
Table 85. Global Hepatitis A immunoglobulin Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Hepatitis A immunoglobulin Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Hepatitis A immunoglobulin Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Hepatitis A immunoglobulin Sales Forecast by Application (2023-2028) & (Doses)
Table 89. Global Hepatitis A immunoglobulin Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Hepatitis A immunoglobulin Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Hepatitis A immunoglobulin Revenue Market Share Forecast by Application (2023-2028)
Table 92. CSL Behring Basic Information, Hepatitis A immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 93. CSL Behring Hepatitis A immunoglobulin Product Offered
Table 94. CSL Behring Hepatitis A immunoglobulin Sales (Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 95. CSL Behring Main Business
Table 96. CSL Behring Latest Developments
Table 97. AIM Vaccine Basic Information, Hepatitis A immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 98. AIM Vaccine Hepatitis A immunoglobulin Product Offered
Table 99. AIM Vaccine Hepatitis A immunoglobulin Sales (Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 100. AIM Vaccine Main Business
Table 101. AIM Vaccine Latest Developments
Table 102. Sinovac Biotech Basic Information, Hepatitis A immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 103. Sinovac Biotech Hepatitis A immunoglobulin Product Offered
Table 104. Sinovac Biotech Hepatitis A immunoglobulin Sales (Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 105. Sinovac Biotech Main Business
Table 106. Sinovac Biotech Latest Developments
Table 107. Pukang Biotechnology Basic Information, Hepatitis A immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 108. Pukang Biotechnology Hepatitis A immunoglobulin Product Offered
Table 109. Pukang Biotechnology Hepatitis A immunoglobulin Sales (Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 110. Pukang Biotechnology Main Business
Table 111. Pukang Biotechnology Latest Developments
Table 112. Zhifei Biological Products Basic Information, Hepatitis A immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 113. Zhifei Biological Products Hepatitis A immunoglobulin Product Offered
Table 114. Zhifei Biological Products Hepatitis A immunoglobulin Sales (Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 115. Zhifei Biological Products Main Business
Table 116. Zhifei Biological Products Latest Developments
Table 117. Changchun Lnstitute Of Biological Products Basic Information, Hepatitis A immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 118. Changchun Lnstitute Of Biological Products Hepatitis A immunoglobulin Product Offered
Table 119. Changchun Lnstitute Of Biological Products Hepatitis A immunoglobulin Sales (Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 120. Changchun Lnstitute Of Biological Products Main Business
Table 121. Changchun Lnstitute Of Biological Products Latest Developments
Table 122. Native Antigen Basic Information, Hepatitis A immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 123. Native Antigen Hepatitis A immunoglobulin Product Offered
Table 124. Native Antigen Hepatitis A immunoglobulin Sales (Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 125. Native Antigen Main Business
Table 126. Native Antigen Latest Developments
Table 127. GSK Basic Information, Hepatitis A immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 128. GSK Hepatitis A immunoglobulin Product Offered
Table 129. GSK Hepatitis A immunoglobulin Sales (Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 130. GSK Main Business
Table 131. GSK Latest Developments
Table 132. Merck Basic Information, Hepatitis A immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 133. Merck Hepatitis A immunoglobulin Product Offered
Table 134. Merck Hepatitis A immunoglobulin Sales (Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 135. Merck Main Business
Table 136. Merck Latest Developments
Table 137. Sanofi Basic Information, Hepatitis A immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 138. Sanofi Hepatitis A immunoglobulin Product Offered
Table 139. Sanofi Hepatitis A immunoglobulin Sales (Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 140. Sanofi Main Business
Table 141. Sanofi Latest Developments
Table 142. Dr. Reddy's Laboratories Basic Information, Hepatitis A immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 143. Dr. Reddy's Laboratories Hepatitis A immunoglobulin Product Offered
Table 144. Dr. Reddy's Laboratories Hepatitis A immunoglobulin Sales (Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 145. Dr. Reddy's Laboratories Main Business
Table 146. Dr. Reddy's Laboratories Latest Developments
LIST OF FIGURES
Figure 1. Picture of Hepatitis A immunoglobulin
Figure 2. Hepatitis A immunoglobulin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hepatitis A immunoglobulin Sales Growth Rate 2017-2028 (Doses)
Figure 7. Global Hepatitis A immunoglobulin Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Hepatitis A immunoglobulin Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Inactivated
Figure 10. Product Picture of Attenuated
Figure 11. Global Hepatitis A immunoglobulin Sales Market Share by Type in 2021
Figure 12. Global Hepatitis A immunoglobulin Revenue Market Share by Type (2017-2022)
Figure 13. Hepatitis A immunoglobulin Consumed in Hospital
Figure 14. Global Hepatitis A immunoglobulin Market: Hospital (2017-2022) & (Doses)
Figure 15. Hepatitis A immunoglobulin Consumed in Pharmacy
Figure 16. Global Hepatitis A immunoglobulin Market: Pharmacy (2017-2022) & (Doses)
Figure 17. Hepatitis A immunoglobulin Consumed in Other
Figure 18. Global Hepatitis A immunoglobulin Market: Other (2017-2022) & (Doses)
Figure 19. Global Hepatitis A immunoglobulin Sales Market Share by Application (2017-2022)
Figure 20. Global Hepatitis A immunoglobulin Revenue Market Share by Application in 2021
Figure 21. Hepatitis A immunoglobulin Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Hepatitis A immunoglobulin Revenue Market Share by Company in 2021
Figure 23. Global Hepatitis A immunoglobulin Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Hepatitis A immunoglobulin Revenue Market Share by Geographic Region in 2021
Figure 25. Global Hepatitis A immunoglobulin Sales Market Share by Region (2017-2022)
Figure 26. Global Hepatitis A immunoglobulin Revenue Market Share by Country/Region in 2021
Figure 27. Americas Hepatitis A immunoglobulin Sales 2017-2022 (Doses)
Figure 28. Americas Hepatitis A immunoglobulin Revenue 2017-2022 ($ Millions)
Figure 29. APAC Hepatitis A immunoglobulin Sales 2017-2022 (Doses)
Figure 30. APAC Hepatitis A immunoglobulin Revenue 2017-2022 ($ Millions)
Figure 31. Europe Hepatitis A immunoglobulin Sales 2017-2022 (Doses)
Figure 32. Europe Hepatitis A immunoglobulin Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Hepatitis A immunoglobulin Sales 2017-2022 (Doses)
Figure 34. Middle East & Africa Hepatitis A immunoglobulin Revenue 2017-2022 ($ Millions)
Figure 35. Americas Hepatitis A immunoglobulin Sales Market Share by Country in 2021
Figure 36. Americas Hepatitis A immunoglobulin Revenue Market Share by Country in 2021
Figure 37. United States Hepatitis A immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Hepatitis A immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Hepatitis A immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Hepatitis A immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Hepatitis A immunoglobulin Sales Market Share by Region in 2021
Figure 42. APAC Hepatitis A immunoglobulin Revenue Market Share by Regions in 2021
Figure 43. China Hepatitis A immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Hepatitis A immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Hepatitis A immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Hepatitis A immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Hepatitis A immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Hepatitis A immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Hepatitis A immunoglobulin Sales Market Share by Country in 2021
Figure 50. Europe Hepatitis A immunoglobulin Revenue Market Share by Country in 2021
Figure 51. Germany Hepatitis A immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Hepatitis A immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Hepatitis A immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Hepatitis A immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Hepatitis A immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Hepatitis A immunoglobulin Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Hepatitis A immunoglobulin Revenue Market Share by Country in 2021
Figure 58. Egypt Hepatitis A immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Hepatitis A immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Hepatitis A immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Hepatitis A immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Hepatitis A immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Hepatitis A immunoglobulin in 2021
Figure 64. Manufacturing Process Analysis of Hepatitis A immunoglobulin
Figure 65. Industry Chain Structure of Hepatitis A immunoglobulin
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Figure 1. Picture of Hepatitis A immunoglobulin
Figure 2. Hepatitis A immunoglobulin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hepatitis A immunoglobulin Sales Growth Rate 2017-2028 (Doses)
Figure 7. Global Hepatitis A immunoglobulin Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Hepatitis A immunoglobulin Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Inactivated
Figure 10. Product Picture of Attenuated
Figure 11. Global Hepatitis A immunoglobulin Sales Market Share by Type in 2021
Figure 12. Global Hepatitis A immunoglobulin Revenue Market Share by Type (2017-2022)
Figure 13. Hepatitis A immunoglobulin Consumed in Hospital
Figure 14. Global Hepatitis A immunoglobulin Market: Hospital (2017-2022) & (Doses)
Figure 15. Hepatitis A immunoglobulin Consumed in Pharmacy
Figure 16. Global Hepatitis A immunoglobulin Market: Pharmacy (2017-2022) & (Doses)
Figure 17. Hepatitis A immunoglobulin Consumed in Other
Figure 18. Global Hepatitis A immunoglobulin Market: Other (2017-2022) & (Doses)
Figure 19. Global Hepatitis A immunoglobulin Sales Market Share by Application (2017-2022)
Figure 20. Global Hepatitis A immunoglobulin Revenue Market Share by Application in 2021
Figure 21. Hepatitis A immunoglobulin Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Hepatitis A immunoglobulin Revenue Market Share by Company in 2021
Figure 23. Global Hepatitis A immunoglobulin Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Hepatitis A immunoglobulin Revenue Market Share by Geographic Region in 2021
Figure 25. Global Hepatitis A immunoglobulin Sales Market Share by Region (2017-2022)
Figure 26. Global Hepatitis A immunoglobulin Revenue Market Share by Country/Region in 2021
Figure 27. Americas Hepatitis A immunoglobulin Sales 2017-2022 (Doses)
Figure 28. Americas Hepatitis A immunoglobulin Revenue 2017-2022 ($ Millions)
Figure 29. APAC Hepatitis A immunoglobulin Sales 2017-2022 (Doses)
Figure 30. APAC Hepatitis A immunoglobulin Revenue 2017-2022 ($ Millions)
Figure 31. Europe Hepatitis A immunoglobulin Sales 2017-2022 (Doses)
Figure 32. Europe Hepatitis A immunoglobulin Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Hepatitis A immunoglobulin Sales 2017-2022 (Doses)
Figure 34. Middle East & Africa Hepatitis A immunoglobulin Revenue 2017-2022 ($ Millions)
Figure 35. Americas Hepatitis A immunoglobulin Sales Market Share by Country in 2021
Figure 36. Americas Hepatitis A immunoglobulin Revenue Market Share by Country in 2021
Figure 37. United States Hepatitis A immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Hepatitis A immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Hepatitis A immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Hepatitis A immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Hepatitis A immunoglobulin Sales Market Share by Region in 2021
Figure 42. APAC Hepatitis A immunoglobulin Revenue Market Share by Regions in 2021
Figure 43. China Hepatitis A immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Hepatitis A immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Hepatitis A immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Hepatitis A immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Hepatitis A immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Hepatitis A immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Hepatitis A immunoglobulin Sales Market Share by Country in 2021
Figure 50. Europe Hepatitis A immunoglobulin Revenue Market Share by Country in 2021
Figure 51. Germany Hepatitis A immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Hepatitis A immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Hepatitis A immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Hepatitis A immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Hepatitis A immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Hepatitis A immunoglobulin Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Hepatitis A immunoglobulin Revenue Market Share by Country in 2021
Figure 58. Egypt Hepatitis A immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Hepatitis A immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Hepatitis A immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Hepatitis A immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Hepatitis A immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Hepatitis A immunoglobulin in 2021
Figure 64. Manufacturing Process Analysis of Hepatitis A immunoglobulin
Figure 65. Industry Chain Structure of Hepatitis A immunoglobulin
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
